
The Wall Street Journal @WSJ
An RSV vaccine that Moderna is developing significantly reduced the risk of respiratory diseases in a key study, the company said https://t.co/DV1L3XL3Z9 — PolitiTweet.org
Created
Tue Jan 17 21:15:06 +0000 2023
Likes
61
Retweets
7
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableThe Wall Street Journal @WSJ
An RSV vaccine that Moderna is developing significantly reduced the risk of respiratory diseases in a key study, the company said https://t.co/DV1L3XL3Z9 — PolitiTweet.org